Lixte Biotechnology Holdings Inc (LIXT)

Currency in USD
3.090
+0.100(+3.34%)
Closed·
3.0900.000(0.00%)
·
LIXT is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
2.8723.234
52 wk Range
0.6406.260
Key Statistics
Prev. Close
2.965
Open
2.99
Day's Range
2.872-3.234
52 wk Range
0.64-6.26
Volume
61.78K
Average Volume (3m)
67.66K
1-Year Change
147.1802%
Book Value / Share
0.52
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
LIXT Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Significant return over the last week
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Lixte Biotechnology Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on identifying targets for cancer drug development, and developing and commercializing cancer therapies. Its lead product candidate, LB-100 is in phase 1b clinical trials combined with Atezolizumab for patients with microsatellite stable metastatic colorectal cancer. The company’s LB-100 combined with doxorubicin in advanced soft tissue sarcoma is under Phase 1b portion; and LB-100 combined with dostarlimab that is in phase 1b/2 for ovarian clear cell carcinoma. The company has a clinical trial research agreement with the Netherlands Cancer Institute; collaboration agreement for an investigator-initiated clinical trial with the Spanish Sarcoma Group; and a development collaboration agreement with the Netherlands Cancer Institute. Lixte Biotechnology Holdings, Inc. was founded in 2005 and is based in Pasadena, California.

Compare LIXT to Peers and Sector

Metrics to compare
LIXT
Peers
Sector
Relationship
P/E Ratio
−6.6x−3.5x−0.4x
PEG Ratio
−0.20−0.090.00
Price/Book
11.6x5.0x2.6x
Price / LTM Sales
-5.8x3.1x
Upside (Analyst Target)
-153.3%57.3%
Fair Value Upside
Unlock18.5%8.0%Unlock
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
12/11/2025
EPS / Forecast
-0.33 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

People Also Watch

2.840
SNT
-2.41%
40.910
LINC
+0.15%
6.860
AP
-2.83%
1.74
JDZG
-8.90%
18.300
LWAY
-1.35%

FAQ

What Is the Lixte Bio (LIXT) Share Price Today?

The Lixte Bio stock price today is 3.090 USD.

What Stock Exchange Does Lixte Bio (LIXT) Trade On?

Lixte Bio is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for Lixte Bio?

The stock symbol (also called a 'ticker') for Lixte Bio is "LIXT."

What Is the Current Lixte Bio Market Cap?

As of today, Lixte Bio market cap is 27.360M USD.

What Is Lixte Bio's (LIXT) Earnings Per Share (TTM)?

The Lixte Bio EPS is currently -1.211 (Trailing Twelve Months).

Is LIXT a Buy or Sell From a Technical Analyst Perspective?

Based on today's Lixte Bio moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Lixte Bio Stock Split?

Lixte Bio has split 2 times. (See the LIXT stock split history page for full effective split date and price information.)

How Many Employees Does Lixte Bio Have?

Lixte Bio has 2 employees.

What is the current trading status of Lixte Bio (LIXT)?

As of 27/03/2026, Lixte Bio (LIXT) is trading at a price of 3.090 USD, with a previous close of 2.965 USD. The stock has fluctuated within a day range of 2.872 USD to 3.234 USD, while its 52-week range spans from 0.640 USD to 6.260 USD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.